東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Metabolism- Disorders" ]

切換: 標籤 | MARC模式 | ISBD

Reviews on biomarker studies of meta...

Guest, Paul C.

FindBook

Google Book

Amazon

博客來

Reviews on biomarker studies of metabolic and metabolism-related disorders

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Reviews on biomarker studies of metabolic and metabolism-related disorders/ edited by Paul C. Guest.
其他作者:	Guest, Paul C.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	xi, 303 p. :ill., digital ;24 cm.
內容註:	1. Insulin Resistance in Schizophrenia -- 2. Biogenesis of the Insulin Secretory Granule in Health and Disease -- 3. Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions -- 4. Preclinical Models of Altered Early Life Nutrition and Development of Reproductive Disorders in Female Offspring -- 5. Targeting Mitochondrial Defects to Increase Lngevity in Animal Models of Neurodegenerative Diseases -- 6. Computational Approaches for Identification of Pleiotropic Biomarker Profiles in Psychiatry -- 7. MiRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-Alcoholic Fatty Liver Disease -- 8. Hypercaloric Diet-Induced Obesity and Obesity-Related Metabolic Disorders in Experimental Models -- 9. Metabolic Biomarkers in Nematode C. elegans During Aging -- 10. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases -- 11. Deciphering Endothelial Dysfunction in the HIV-Infected Population -- 12. The Role of Inflammation in the Development of GDM and The Use of Markers of Inflammation in GDM Screening -- 13. PFKP Signaling at a Glance: an Emerging Mediator of Cancer Cell Metabolism -- 14. ATAD3A on the Path to Cancer -- 15. Impact of Exercise on Inflammatory Mediators of Metabolic and Vascular Insulin Resistance in Type 2 Diabetes.
Contained By:	Springer eBooks
標題:	Metabolism - Disorders -
電子資源:	https://doi.org/10.1007/978-3-030-12668-1
ISBN:	9783030126681

Reviews on biomarker studies of metabolic and metabolism-related disorders
Reviews on biomarker studies of metabolic and metabolism-related disorders[electronic resource] /edited by Paul C. Guest. - Cham :Springer International Publishing :2019. - xi, 303 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology ;v.1134. - Advances in experimental medicine and biology.Proteomics, metabolomics, interactomics and systems biology ;v.1134..

1. Insulin Resistance in Schizophrenia -- 2. Biogenesis of the Insulin Secretory Granule in Health and Disease -- 3. Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions -- 4. Preclinical Models of Altered Early Life Nutrition and Development of Reproductive Disorders in Female Offspring -- 5. Targeting Mitochondrial Defects to Increase Lngevity in Animal Models of Neurodegenerative Diseases -- 6. Computational Approaches for Identification of Pleiotropic Biomarker Profiles in Psychiatry -- 7. MiRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-Alcoholic Fatty Liver Disease -- 8. Hypercaloric Diet-Induced Obesity and Obesity-Related Metabolic Disorders in Experimental Models -- 9. Metabolic Biomarkers in Nematode C. elegans During Aging -- 10. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases -- 11. Deciphering Endothelial Dysfunction in the HIV-Infected Population -- 12. The Role of Inflammation in the Development of GDM and The Use of Markers of Inflammation in GDM Screening -- 13. PFKP Signaling at a Glance: an Emerging Mediator of Cancer Cell Metabolism -- 14. ATAD3A on the Path to Cancer -- 15. Impact of Exercise on Inflammatory Mediators of Metabolic and Vascular Insulin Resistance in Type 2 Diabetes.

The book recognizes that throughout the scientific, medical, and economic communities, new tests incorporating biomarkers are needed to improve the diagnosis of patients suffering from metabolic disorders. The early identification of those at risk of developing obesity will help to place these individuals on the best treatment course as early as possible for improved treatment outcomes. This will also help to cut costs incurred by the healthcare services. For all of this to occur, new research efforts are needed to identify novel biomarkers that can be used to predict the disease in the presymptomatic stage, for disease monitoring and for prediction of treatment response. It is also possible that new drug targets can be identified using these approaches which, in turn, can lead to the development of new treatment approaches. This volume also includes a series of reviews on biomarker discovery and usage in the study of diseases marked by perturbations in metabolism. It will describe the pros and cons of the various approaches and cover the successes and failures in this important research field.

ISBN: 9783030126681

Standard No.: 10.1007/978-3-030-12668-1doiSubjects--Topical Terms:

3386119
Metabolism
--Disorders

LC Class. No.: RC627.54

Dewey Class. No.: 616.39

Reviews on biomarker studies of metabolic and metabolism-related disorders
LDR:03562nmm a2200337 a 4500 001 2180231
003 DE-He213
005 20190327161046.0
006 m d
007 cr nn 008maaau
008 191122s2019 gw s 0 eng d
020 $a 9783030126681 $q (electronic bk.)
020 $a 9783030126674 $q (paper)
024 7 $a 10.1007/978-3-030-12668-1 $2 doi
035 $a 978-3-030-12668-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC627.54
072 7 $a PSBC $2 bicssc
072 7 $a SCI007000 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 616.39 $2 23
090 $a RC627.54 $b .R454 2019
245 0 0 $a Reviews on biomarker studies of metabolic and metabolism-related disorders $h [electronic resource] / $c edited by Paul C. Guest.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xi, 303 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology ; $v v.1134
505 0 $a 1. Insulin Resistance in Schizophrenia -- 2. Biogenesis of the Insulin Secretory Granule in Health and Disease -- 3. Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions -- 4. Preclinical Models of Altered Early Life Nutrition and Development of Reproductive Disorders in Female Offspring -- 5. Targeting Mitochondrial Defects to Increase Lngevity in Animal Models of Neurodegenerative Diseases -- 6. Computational Approaches for Identification of Pleiotropic Biomarker Profiles in Psychiatry -- 7. MiRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-Alcoholic Fatty Liver Disease -- 8. Hypercaloric Diet-Induced Obesity and Obesity-Related Metabolic Disorders in Experimental Models -- 9. Metabolic Biomarkers in Nematode C. elegans During Aging -- 10. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases -- 11. Deciphering Endothelial Dysfunction in the HIV-Infected Population -- 12. The Role of Inflammation in the Development of GDM and The Use of Markers of Inflammation in GDM Screening -- 13. PFKP Signaling at a Glance: an Emerging Mediator of Cancer Cell Metabolism -- 14. ATAD3A on the Path to Cancer -- 15. Impact of Exercise on Inflammatory Mediators of Metabolic and Vascular Insulin Resistance in Type 2 Diabetes.
520 $a The book recognizes that throughout the scientific, medical, and economic communities, new tests incorporating biomarkers are needed to improve the diagnosis of patients suffering from metabolic disorders. The early identification of those at risk of developing obesity will help to place these individuals on the best treatment course as early as possible for improved treatment outcomes. This will also help to cut costs incurred by the healthcare services. For all of this to occur, new research efforts are needed to identify novel biomarkers that can be used to predict the disease in the presymptomatic stage, for disease monitoring and for prediction of treatment response. It is also possible that new drug targets can be identified using these approaches which, in turn, can lead to the development of new treatment approaches. This volume also includes a series of reviews on biomarker discovery and usage in the study of diseases marked by perturbations in metabolism. It will describe the pros and cons of the various approaches and cover the successes and failures in this important research field.
650 0 $a Metabolism $x Disorders $x Research. $3 3386119
650 0 $a Biochemical markers $x Research. $3 2156236
650 1 4 $a Proteomics. $3 600542
650 2 4 $a Gene Function. $3 1067308
650 2 4 $a Diabetes. $3 544344
700 1 $a Guest, Paul C. $3 3219137
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology. $p Proteomics, metabolomics, interactomics and systems biology ; $v v.1134. $3 3386118
856 4 0 $u https://doi.org/10.1007/978-3-030-12668-1
950 $a Biomedical and Life Sciences (Springer-11642)